Tdap Vaccination for Infant Caregivers

This study has been completed.
Sponsor:
Collaborator:
Saint Raphael Healthcare System
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT01233401
First received: November 1, 2010
Last updated: July 26, 2011
Last verified: July 2011
  Purpose

This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.


Condition Intervention
Pertussis
Vaccination
Other: Survey

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Tdap Vaccination for Infant Caregivers in the Pediatric Office

Resource links provided by NLM:


Further study details as provided by Yale University:

Primary Outcome Measures:
  • Maternal Tdap Vaccination Rate [ Time Frame: At 2 week well child visit ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Other Infant Caregiver Tdap Vaccination Rate [ Time Frame: At 2 week well child visit ] [ Designated as safety issue: No ]

Enrollment: 102
Study Start Date: June 2010
Study Completion Date: June 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Mothers Other: Survey
Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.
Other Infant Caregivers
Includes fathers, grandparents, and other adults who are infant caregivers
Other: Survey
Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

  Eligibility

Ages Eligible for Study:   18 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

18-64 year old men and women who are mothers or other infant caregivers of 2 week old infants

Criteria

Inclusion Criteria:

  • 18-64 years old
  • English or Spanish speaking

Exclusion Criteria:

  • Do not speak English or Spanish
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01233401

Locations
United States, Connecticut
Hospital of St. Raphael
New Haven, Connecticut, United States, 06511
Sponsors and Collaborators
Yale University
Saint Raphael Healthcare System
Investigators
Principal Investigator: Deepa R Camenga, MD Yale University
Principal Investigator: Marjorie Rosenthal, MD MPH Yale University
  More Information

No publications provided

Responsible Party: Deepa Camenga, MD, Yale University
ClinicalTrials.gov Identifier: NCT01233401     History of Changes
Other Study ID Numbers: 1005006837
Study First Received: November 1, 2010
Last Updated: July 26, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Yale University:
Pertussis, Vaccination, Adult

Additional relevant MeSH terms:
Whooping Cough
Bordetella Infections
Gram-Negative Bacterial Infections
Bacterial Infections
Respiratory Tract Infections
Infection
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on April 17, 2014